netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Canagliflozin found 9 matches
Open monograph to display formulary status BNF Category
  Canagliflozin Endocrine system - SGL2 inhibitors - 06.01.02.03
  Canagliflozin/Metformin  (Vokanamet®) Endocrine system - Other antidiabetic drugs - 06.01.02.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA: Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients (06.01.02.03)
link in drug section MHRA: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis (06.01.02.03)
link in drug section MHRA: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis (06.01.02.03)
link in drug section NICE TA315: Canagliflozin in combination therapy for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)


 
netFormulary